Naperville, IL -- (SBWIRE) -- 02/17/2015 -- Reportstack, provider of premium market research reports announces the addition of Global Preventable Vaccines Market 2015-2019 market report to its offering
About Preventable Vaccines
Vaccines can be defined as a product that stimulates a person’s immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and adolescents. Pediatric vaccines are used for the immunization of children to give protection against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the classification adopted by the US FDA, children are classified as newborn, infant, and adolescent, ranging from birth to 21 years of age. However, the EMA classifies pediatrics as ranging from birth to 18 years of age.
Analysts forecast the Global Preventable Vaccines market to grow at a CAGR of 10.16 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Preventable Vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of preventable vaccines. The report examines the market for vaccines used in humans. It covers only commercialized vaccines for diseases that are vaccine preventable.
The report does not cover emerging vaccines for diseases that are not currently vaccine preventable, such as Ebola infection, Epstein-Ban virus infection, Alzheimer's disease, diabetes, Helicobacter pylori infection, multiple sclerosis, Parkinson's disease, or West Nile virus infection.
The report has broadly categorized preventable vaccines into two major segments:
- Adult Preventable Vaccines
- Pediatric Preventable Vaccines
Global Preventable Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Preventable Vaccines market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
- Americas
- APAC
- EMEA
Key Vendors
- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Sanofi
Other Prominent Vendors
- Abbott
- AstraZeneca
- Bavarian Nordic
- Baxter
- Bharat Biotech
- Bharat Immunologicals and Biologicals
- bioCSL
- Bio Med
- Crucell
- Dynavax Technologies
- Indian Immunologicals
- Janssen Pharmaceuticals
- Kaketsuken
- LG Life Sciences
- Mitsubishi Tanabe Pharma
- Lupin
- Nuron
- Protein Sciences
- Panacea Biotec
- Roche
- Serum Institute of India
- Shenzhen Kangtai Biological Products
- Serum Institute of India
- Sinovac Biotech
- S K Chemicals
- Takeda Pharmaceutical
- Valeant Pharmaceuticals
- Zydus Cadila
Market Driver
- Inclusion in NIP
- For a full, detailed list, view our report
Market Challenge
- Inadequate Vaccine Coverage
- For a full, detailed list, view our report
Market Trend
- Increase in Strategic Alliances
- For a full, detailed list, view our report
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Complete report is available
http://www.reportstack.com/product/191955/global-preventable-vaccines-market-2015-2019.html
Contact:
Roger Campbell
roger@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604